# AgentOS Governance Evaluation Demo

## Buyer Brief
- Product: SCRIMED AgentOS
- Buyer: AI governance, compliance, innovation, clinical transformation, and executive leaders
- Agent: Planner, Router, Specialist Agents, and TrustQA
- Status: executable-demo
- Executable route: /evaluation

## Objective
Demonstrate how a synthetic enterprise workflow packet becomes a governed multi-agent plan and Atlas Trust Card.

## Synthetic Scenario
An interactive synthetic packet is assigned structural document intelligence, routed through AgentOS, checked by TrustQA, and packaged with approvals, audit preview, and observability signals.

## Guided Evaluation
- Choose a synthetic evaluation scenario.
- Generate an AgentOS task plan and structural parser assignment.
- Inspect the Atlas Trust Card, evidence sources, and confidence posture.
- Review approval checkpoints, audit preview, and denied capabilities.

## Inspectable Proof
- [Agent registry](/agents): Planner, router, specialist registry, permissions, and review policies.
- [Audit governance](/audit): Approval checkpoints, AI Asset Registry, and audit channels.
- [Trust layer](/trust): TrustQA, provenance, Trust Cards, and production boundaries.

## Inspectable Outcomes
- Multi-agent task plan
- Atlas Trust Card
- Human approval checkpoints
- Audit and observability preview

## Success Signals
- Governance gaps surfaced
- Agent responsibilities clarified
- Trust completeness made inspectable
- Denied capabilities retained

## Governance Boundaries
- Synthetic document packets only.
- Human approval checkpoints remain required.
- Production requests are denied by default.

## Production Exclusions
- No live PHI ingestion
- No autonomous clinical execution
- No production connector access
- No payer or patient-facing action

## Product Boundary
SCRIMED demos and pilot programs are governed synthetic evaluations for enterprise buyers. They do not ingest live PHI, diagnose, treat, submit payer transactions, contact patients, mutate production records, or autonomously execute clinical care.

This brief supports enterprise evaluation and pilot scoping. It is not clinical advice, a production authorization, a certification claim, or evidence of autonomous clinical execution.